Alinia
NDC Package 27437-106-01
Package Information
Alinia is diarrhea caused by Giardia lambliaor Cryptosporidium parvum:ALINIA for Oral Suspension (patients 1 year of age and older) and ALINIA Tablets (patients 12 years and older) are indicated for the treatment of diarrhea caused by Giardia lambliaor Cryptosporidium parvum. Marketed by Lupin Pharmaceuticals, Inc., this product is identified by NDC 27437-106 and is authorized under FDA application NDA021498.
Identification & Billing
- RxCUI: 359822 - nitazoxanide 100 MG in 5 mL Oral Suspension
- RxCUI: 359822 - nitazoxanide 20 MG/ML Oral Suspension
- RxCUI: 359822 - nitazoxanide 100 MG per 5 ML Oral Powder for Suspension
- RxCUI: 359822 - nitazoxanide 100 MG per 5 ML Oral Suspension
- RxCUI: 404419 - Alinia 100 MG in 5 mL Oral Suspension
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 27437 - Lupin Pharmaceuticals, Inc.
- 27437-106 - Alinia
- 27437-106-01 - 1 BOTTLE, GLASS in 1 CARTON / 60 mL in 1 BOTTLE, GLASS
- 27437-106 - Alinia
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 27437-106-01 identifies a specific commercial package of 1 bottle, glass in 1 carton / 60 ml in 1 bottle, glass of Alinia, labeled by Lupin Pharmaceuticals, Inc.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Lupin Pharmaceuticals, Inc. on October 09, 2013. The current certification is valid through December 31, 2025.
How is this Lupin Pharmaceuticals, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 27437010601. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 60 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.